In multiple myeloma concentration of angiogenic factors (VEGF, bFGF, and HGF) is higher in bone marrow than in peripheral blood.

被引：0
|
作者：
Di Raimondo, F [1 ]
Azzaro, MP [1 ]
Palumbo, GA [1 ]
Bagnato, S [1 ]
Sortino, G [1 ]
Giustolisi, R [1 ]
机构：
[1] Univ Catania, Catania, Italy
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4551
引用
收藏
页码：297B / 297B
页数：1
相关论文
共 50 条
  • [31] Th17 Cells Are Increased in the Bone Marrow but Not the Peripheral Blood in Multiple Myeloma and Demonstrate Defective Functionality and Aberrant Phenotypes
    Parrish, Christopher
    Scott, Gina B.
    Cook, Graham
    Cook, Gordon
    [J]. BLOOD, 2014, 124 (21)
  • [32] Single-cell analysis reveals disease induced perturbations of monocytes in the bone marrow and peripheral blood of multiple myeloma patients
    Cui, Jian
    Li, Xiaoyun
    Gao, Xin
    Qiu, Lugui
    An, Gang
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S16 - S16
  • [33] Real time quantitative PCR shows that peripheral blood stem cell (PBPC) harvests are significantly less contaminated than bone marrow (BM) in multiple myeloma patients (MM).
    Ladetto, M
    Omedè, P
    Sametti, S
    Donovan, JW
    Astolfi, M
    Giaccone, L
    Giaretta, F
    Volpato, F
    Bringhen, S
    Palumbo, A
    Bruno, B
    Pileri, A
    Gribben, JG
    Boccadoro, M
    [J]. BLOOD, 2000, 96 (11) : 154A - 154A
  • [34] Measurable Residual Disease in Extracellular Vesicles from Bone Marrow and Peripheral Blood of Patients with Multiple Myeloma: A Proof-of-Concept Study
    Bergantim, Rui
    Barbosa, Melanie A. G.
    da Silva, Sara Peixoto
    Polonia, Barbara
    Caires, Hugo R.
    Guimaraes, Jose E.
    Helena Vasconcelos, M.
    [J]. BLOOD, 2021, 138
  • [35] The significance of light chain-restricted bone marrow plasma cells after peripheral blood stem cell transplantation for multiple myeloma
    Maia, DM
    Kell, DL
    Goates, JJ
    Warnke, RA
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1997, 107 (06) : 643 - 652
  • [36] Bone marrow versus peripheral blood versus CD34+ progenitors as the source of stem cell for autologous in multiple myeloma (MM).
    Harousseau, JL
    Attal, M
    Payen, C
    Facon, T
    Michaux, JL
    Guilhot, F
    Monconduit, M
    Fuzibet, JG
    Caillot, D
    Dorvaux, V
    Cahn, JY
    Grosbois, B
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 : S205 - S205
  • [37] Adhesion molecule immunophenotype of bone marrow multiple myeloma plasma cells impacts the presence of malignant circulating plasma cells in peripheral blood
    Klimiene, Indre
    Radzevicius, Mantas
    Matuzeviciene, Reda
    Sinkevic-Belliot, Katazina
    Kucinskiene, Zita Ausrele
    Peceliunas, Valdas
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (03) : 403 - 408
  • [38] Outpatient management of bone marrow aplasia following high dose melphalan and peripheral blood stem cell infusion in patients with multiple myeloma
    Ferrara, F.
    Annunziata, M.
    Mele, G.
    Copia, C.
    Pollio, F.
    D'Amico, M. R.
    Alberti, M.
    Viola, A.
    D'Elia, R.
    Palmieri, S.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 285 - 285
  • [39] Distinct T Cell Receptor Gene Repertoires and T Cell Subset Distribution in Peripheral Blood and Bone Marrow of Patients with Multiple Myeloma
    Gkoliou, Glykeria
    Pechlivanis, Nikolaos
    Chatzileontiadou, Sofia
    Xydopoulou, Chara
    Frouzaki, Christina
    Karakatsoulis, Georgios
    Vlachonikola, Elisavet
    Gerousi, Marina
    Psomopoulos, Fotis
    Papaioannou, Maria
    Chlichlia, Katerina
    Stamatopoulos, Kostas
    Hatjiharissi, Evdoxia
    Chatzidimitriou, Anastasia
    [J]. BLOOD, 2023, 142
  • [40] Higher percentage of donor CD 34+ expression in peripheral blood of simultaneous pancreas kidney donor bone marrow versus than kidney islet cell donor bone marrow recipients
    Burke, GW
    Ciancio, G
    Garcia-Morales, R
    Ricordi, C
    Alejandro, R
    Roth, D
    Tzakis, A
    Miller, J
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (02) : 535 - 536
12345